Utah Medical Products (UTMD) Net Margin (2010 - 2026)

Utah Medical Products' Net Margin history runs 17 years deep, the most recent figure standing at 29.86% for Q1 2026.

• On a quarterly basis, Net Margin fell 146.0% year-over-year to 29.86% in Q1 2026; TTM through Mar 2026 was 27.27%, a 43.0% decrease from a year earlier, with the FY2025 full-year figure at 27.71%, down 654.0% from the prior year.
• Net Margin climbed to 29.86% in Q1 2026 per UTMD's latest filing, from 21.58% in the prior quarter.
• Across five years, Net Margin topped out at 60.78% in Q4 2022 and bottomed at 28.58% in Q4 2023.
• The 5-year median for Net Margin is 31.32% (2025), against an average of 27.95%.
• Across the five-year window, Net Margin jumped 12174 bps in 2022 and plunged 8936 bps in 2023, its largest moves.
• Year by year, Net Margin stood at 60.78% in 2022, then slumped by 147 bps to 28.58% in 2023, then soared by 131 bps to 8.95% in 2024, then jumped by 141 bps to 21.58% in 2025, then soared by 38 bps to 29.86% in 2026.
• Per Business Quant, the three latest UTMD Net Margin figures stand at 29.86% (Q1 2026), 21.58% (Q4 2025), and 26.81% (Q3 2025).